Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

371

HTML

2521

Figures (1-2)

122

Tables (1-5)

117

Sum=3131

Feb 7, 2006 (publication date) through Apr 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 7, 2006; 12(5): 747-754
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.747

Figure 1 Disposition of patients in the treatment phase.

Figure 2 The frequency of heartburn, regurgitation, pain and sleep disturbance.

Citation: Lai IR, Wu MS, Lin JT. Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease. World J Gastroenterol 2006; 12(5): 747-754
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/747.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.747